Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

The medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.

In 2021, approval of cabotegravir (Apretude) as the first long-acting PrEP option provided patients an option to move from ...

The NHS is calling for 200,000 new donors to come forward as it warns of a "challenging" blood supply shortage. Currently ...

A Houston physician has sued the federal government to cut benefits through the Affordable Care Act that requires access to ...

The PURPOSE trials illuminated the ways in which lenacapavir could be used as a means of pre-exposure prophylaxis effectively, but also featured several adverse events.

The Trump administration is planning to eliminate the Centers for Disease Control and Prevention’s Division of HIV Prevention. The collapse of HIV prevention will mean 143,000 additional people in the ...

On Monday, analysts at Morgan Stanley reiterated their Overweight rating on Gilead Sciences, Inc. (NASDAQ:GILD), while ...

Here’s a look at the origins, treatments and global response to HIV and AIDS. Facts HIV stands for human immunodeficiency virus. AIDS stands for acquired immunodeficiency syndrome. HIV/AIDS is spread ...

Of 49 countries surveyed in a recent analysis, 15 have historically relied on the the U.S. for most of the funding for their ...

Healthcare groups and policy experts expressed concern about cuts included in the Trump administration's full budget proposal ...